Annual Non Current Assets
$81.00 K
-$45.00 K-35.71%
December 31, 2023
Summary
- As of February 7, 2025, CANF annual long term assets is $81.00 thousand, with the most recent change of -$45.00 thousand (-35.71%) on December 31, 2023.
- During the last 3 years, CANF annual non current assets has fallen by -$42.00 thousand (-34.15%).
- CANF annual non current assets is now -92.14% below its all-time high of $1.03 million, reached on December 31, 2019.
Performance
CANF Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$94.00 K
+$13.00 K+16.05%
June 30, 2024
Summary
- As of February 7, 2025, CANF quarterly long term assets is $94.00 thousand, with the most recent change of +$13.00 thousand (+16.05%) on June 30, 2024.
- Over the past year, CANF quarterly non current assets has dropped by -$29.00 thousand (-23.58%).
- CANF quarterly non current assets is now -94.94% below its all-time high of $1.86 million, reached on June 30, 2018.
Performance
CANF Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
CANF Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.7% | -23.6% |
| 3 y3 years | -34.1% | -26.0% |
| 5 y5 years | +65.3% | +95.8% |
CANF Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.2% | at low | -49.2% | +16.1% |
| 5 y | 5-year | -92.1% | at low | -90.9% | +16.1% |
| alltime | all time | -92.1% | +98.5% | -94.9% | +130.4% |
Can-Fite BioPharma Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $94.00 K(+16.0%) |
| Dec 2023 | $9.91 M(+8.2%) | $81.00 K(-22.9%) |
| Sep 2023 | - | $105.00 K(-14.6%) |
| Jun 2023 | - | $123.00 K(+11.8%) |
| Mar 2023 | - | $110.00 K(-12.7%) |
| Dec 2022 | $9.16 M(-54.4%) | $126.00 K(-10.6%) |
| Sep 2022 | - | $141.00 K(-10.2%) |
| Jun 2022 | - | $157.00 K(-9.8%) |
| Mar 2022 | - | $174.00 K(-5.9%) |
| Dec 2021 | $20.07 M(+113.5%) | $185.00 K(+12.1%) |
| Sep 2021 | - | $165.00 K(+29.9%) |
| Jun 2021 | - | $127.00 K(+8.5%) |
| Mar 2021 | - | $117.00 K(-4.9%) |
| Dec 2020 | $9.40 M(+31.6%) | $123.00 K(+43.0%) |
| Sep 2020 | - | $86.00 K(-10.4%) |
| Jun 2020 | - | $96.00 K(-90.7%) |
| Dec 2019 | $7.14 M(-9.6%) | - |
| Dec 2019 | - | $1.03 M(-42.7%) |
| Sep 2019 | - | $1.80 M(+3645.8%) |
| Jun 2019 | - | $48.00 K(-2.0%) |
| Mar 2019 | - | $49.00 K(0.0%) |
| Dec 2018 | $7.90 M(+18.6%) | - |
| Dec 2018 | - | $49.00 K(-95.6%) |
| Sep 2018 | - | $1.12 M(-39.7%) |
| Jun 2018 | - | $1.86 M(+94.4%) |
| Mar 2018 | - | $956.00 K(+0.6%) |
| Dec 2017 | $6.66 M | - |
| Dec 2017 | - | $950.00 K(+1611.7%) |
| Sep 2017 | - | $55.50 K(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $61.10 K(-5.4%) |
| Mar 2017 | - | $64.60 K(+2.7%) |
| Dec 2016 | $10.10 M(-42.4%) | - |
| Dec 2016 | - | $62.90 K(-7.8%) |
| Sep 2016 | - | $68.20 K(-0.4%) |
| Jun 2016 | - | $68.50 K(-7.8%) |
| Mar 2016 | - | $74.30 K(+10.2%) |
| Dec 2015 | $17.53 M(+72.8%) | - |
| Dec 2015 | - | $67.40 K(-1.6%) |
| Sep 2015 | - | $68.50 K(-4.9%) |
| Jun 2015 | - | $72.00 K(+55.8%) |
| Mar 2015 | - | $46.20 K(+13.2%) |
| Dec 2014 | $10.15 M(+54.1%) | - |
| Dec 2014 | - | $40.80 K(-13.0%) |
| Sep 2014 | - | $46.90 K(-11.0%) |
| Jun 2014 | - | $52.70 K(-7.7%) |
| Mar 2014 | - | $57.10 K(+12.4%) |
| Dec 2013 | $6.58 M(+315.6%) | $50.80 K(+15.5%) |
| Sep 2013 | - | $44.00 K(-3.3%) |
| Jun 2013 | - | $45.50 K(-2.2%) |
| Mar 2013 | - | $46.50 K(-9.0%) |
| Dec 2012 | $1.58 M(-67.2%) | - |
| Dec 2012 | - | $51.10 K(+17.7%) |
| Sep 2012 | - | $43.40 K(-11.6%) |
| Jun 2012 | - | $49.10 K(-2.4%) |
| Mar 2012 | - | $50.30 K(-31.1%) |
| Dec 2011 | $4.83 M | - |
| Dec 2011 | - | $73.00 K(-30.6%) |
| Sep 2011 | - | $105.20 K |
FAQ
- What is Can-Fite BioPharma annual long term assets?
- What is the all time high annual non current assets for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual non current assets year-on-year change?
- What is Can-Fite BioPharma quarterly long term assets?
- What is the all time high quarterly non current assets for Can-Fite BioPharma?
- What is Can-Fite BioPharma quarterly non current assets year-on-year change?
What is Can-Fite BioPharma annual long term assets?
The current annual non current assets of CANF is $81.00 K
What is the all time high annual non current assets for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual long term assets is $1.03 M
What is Can-Fite BioPharma annual non current assets year-on-year change?
Over the past year, CANF annual long term assets has changed by -$45.00 K (-35.71%)
What is Can-Fite BioPharma quarterly long term assets?
The current quarterly non current assets of CANF is $94.00 K
What is the all time high quarterly non current assets for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly long term assets is $1.86 M
What is Can-Fite BioPharma quarterly non current assets year-on-year change?
Over the past year, CANF quarterly long term assets has changed by -$29.00 K (-23.58%)